How to Get Oral Micronized Progesterone in Missouri

Who Can Prescribe Oral Micronized Progesterone in Missouri

Any Missouri-licensed prescriber with an active DEA registration (though progesterone is not a controlled substance) and prescriptive authority can write a progesterone prescription. That includes MDs, DOs, nurse practitioners, and physician assistants.

Missouri revised statutes (RSMo 334.104) grant full-practice authority to APRNs who have completed a minimum of 2 to 000 hours of supervised practice, meaning NPs can independently prescribe progesterone without physician co-signature after that threshold. PAs must maintain a collaborative practice arrangement with a supervising physician, but the supervision can be remote. For patients in rural Missouri counties where endocrinologists and gynecologists are scarce, NP and PA prescribing significantly widens access.

Board-certified OB-GYNs, reproductive endocrinologists, and menopause-certified internists most frequently prescribe oral micronized progesterone. Primary care physicians also prescribe it as part of combined HRT regimens. The Endocrine Society's 2015 clinical practice guideline recommends micronized progesterone over synthetic progestins for endometrial protection in women using estrogen therapy, citing a more favorable cardiovascular and breast-tissue safety profile [1].

Telehealth Prescribing Rules in Missouri

Missouri permits telehealth prescribing of oral micronized progesterone with no in-person visit requirement, provided the prescriber establishes a valid provider-patient relationship via synchronous audio-video consultation.

Missouri Senate Bill 579 (enacted 2021) codified telehealth parity and removed the prior requirement for an initial face-to-face encounter for non-controlled medications. Because progesterone is not scheduled under Missouri's Controlled Substances Act, a prescriber licensed in Missouri (or holding a Missouri telemedicine license) can evaluate a patient, order labs, and transmit an electronic prescription to any Missouri pharmacy during a single video visit. The Missouri Board of Registration for the Healing Arts requires that telehealth consultations meet the same standard of care as in-person visits, including documentation of medical history, current symptoms, and informed consent.

Typical telehealth workflow for Missouri patients:

1. Complete an intake questionnaire covering menstrual history, menopausal symptoms, and contraindications (active liver disease, known progesterone hypersensitivity, undiagnosed vaginal bleeding).
2. Schedule a synchronous video consultation with a licensed prescriber.
3. Receive lab orders (drawn at any Quest, Labcorp, or independent Missouri lab).
4. After lab review, the prescriber e-prescribes to your chosen Missouri pharmacy.

Most telehealth platforms complete this cycle in 3 to 5 business days.

What Labs Are Required Before Starting Progesterone

Prescribers in Missouri typically order a focused hormone and safety panel before initiating oral micronized progesterone, especially when it is part of a combined estrogen-progesterone HRT regimen.

The baseline panel generally includes serum progesterone, estradiol (E2), follicle-stimulating hormone (FSH), a comprehensive metabolic panel with hepatic transaminases (AST, ALT), and a fasting lipid panel. The PEPI trial (N=875) demonstrated that oral micronized progesterone combined with conjugated equine estrogens preserved HDL cholesterol better than medroxyprogesterone acetate did, with a mean HDL increase of 4.1 mg/dL in the micronized progesterone arm versus a 2.4 mg/dL decrease in the MPA arm at 36 months [2]. That lipid-sparing benefit is one reason clinicians prefer micronized progesterone, but it also makes a baseline lipid panel clinically useful for tracking response.

FSH above 30 mIU/mL alongside low estradiol (<20 pg/mL) confirms menopausal status in women over 45 and helps the prescriber determine whether combined HRT (estrogen plus progesterone) is appropriate. For perimenopausal patients with erratic cycles, a day-21 serum progesterone below 3 ng/mL may indicate anovulation and support the clinical rationale for supplementation [3].

Hepatic function screening matters because oral micronized progesterone undergoes extensive first-pass metabolism in the liver, producing the neuroactive metabolite allopregnanolone. Patients with active hepatic disease or significantly elevated transaminases (ALT >3x upper limit of normal) are generally not candidates for the oral route and may be directed to vaginal or transdermal formulations instead [4].

After initiation, follow-up labs at 6 to 12 weeks typically include repeat progesterone and estradiol levels, plus hepatic function if the baseline was borderline.

Missouri Pharmacy Options: Retail and 503A Compounding

Missouri has both retail chain pharmacies and state-licensed 503A compounding pharmacies that dispense oral micronized progesterone, giving patients multiple fulfillment pathways.

Retail pharmacies (CVS, Walgreens, Walmart, Hy-Vee, and independent pharmacies across the state) stock FDA-approved generic micronized progesterone capsules (100 mg and 200 mg) as well as brand-name Prometrium. Generic cash prices in Missouri typically range from $30 to $90 for a 30-day supply depending on dose and pharmacy, according to pricing data from GoodRx and RxSaver. Prometrium brand can exceed $200 without insurance.

Missouri's Board of Pharmacy licenses 503A compounding pharmacies under RSMo Chapter 338. These pharmacies can compound custom progesterone formulations (for example, progesterone in a peanut-oil-free base for patients with peanut allergy, since Prometrium capsules contain peanut oil). A 2020 FDA advisory committee review noted that micronized progesterone compounded without peanut oil showed comparable bioavailability in small pharmacokinetic studies, though FDA-approved commercial generics remain the first-line recommendation when tolerated.

Compounding pharmacies in Missouri may ship within the state. Some 503B outsourcing facilities can ship across state lines, but for patient-specific 503A prescriptions, the dispensing pharmacy must hold a Missouri license. Patients should verify their compounding pharmacy's accreditation through the Pharmacy Compounding Accreditation Board (PCAB) or directly with the Missouri Board of Pharmacy.

Insurance Coverage and Missouri Medicaid

Missouri Medicaid (MO HealthNet) does not cover oral micronized progesterone for the indication of endometrial protection in hormone replacement therapy. Coverage is limited to progesterone uses tied to specific diagnoses such as type 2 diabetes or secondary amenorrhea.

This coverage gap affects roughly 1.1 million Missourians enrolled in MO HealthNet. For patients relying on Medicaid, the prescriber may need to document medical necessity and pursue an exception request, though approval rates for HRT-related progesterone remain low. The North American Menopause Society's 2022 position statement emphasizes that progestogen therapy is medically necessary for any woman with an intact uterus who receives systemic estrogen, stating: "The addition of a progestogen is recommended for endometrial protection in women with a uterus using systemic estrogen therapy." This language can support appeal letters.

Commercial insurance plans in Missouri (Blue Cross Blue Shield of Kansas City, Anthem, Aetna, UnitedHealthcare, Cigna) generally cover generic micronized progesterone on Tier 1 or Tier 2 formularies with copays between $5 and $25. Brand Prometrium often sits on Tier 3. Prior authorization requirements vary by plan but are uncommon for generic progesterone prescribed with a concurrent estrogen.

For uninsured or underinsured patients, manufacturer discount cards and pharmacy savings programs can reduce generic progesterone costs to $15 to $30 per month. Solvay Pharmaceuticals (now AbbVie) historically offered a Prometrium savings card, and several generic manufacturers maintain patient assistance programs.

Prior Authorization Requirements in Missouri

When prior authorization is required, Missouri insurers typically ask for documentation of menopausal status, concurrent estrogen use, and clinical rationale for the oral route specifically.

Standard documentation includes:

• Diagnosis codes: N95.1 (menopausal and female climacteric states), Z79.890 (long-term use of hormone replacement therapy), or N92.1 (excessive and frequent menstruation with irregular cycle) for perimenopausal patients.
• Lab results confirming menopausal or perimenopausal status (FSH, estradiol).
• Documentation that the patient has an intact uterus and is receiving systemic estrogen therapy.
• Trial and failure of alternative formulations, if the insurer requires step therapy (uncommon for generic micronized progesterone but sometimes required for brand Prometrium).

The American College of Obstetricians and Gynecologists Practice Bulletin No. 141 recommends micronized progesterone as a first-line progestogen for HRT, which strengthens prior authorization appeals. ACOG states that "micronized progesterone may be associated with a better side-effect profile and improved patient adherence compared with synthetic progestins."

Missouri law (RSMo 376.1237) requires health insurers to respond to prior authorization requests within 48 hours for non-urgent requests and 24 hours for urgent requests. If denied, patients have the right to an external review through the Missouri Department of Commerce and Insurance.

Dosing Protocols: Cyclic Versus Continuous

Two standard dosing protocols exist for oral micronized progesterone when used for endometrial protection, and the choice between them depends on menopausal stage and patient preference.

Cyclic dosing prescribes 200 mg nightly for 12 to 14 days per calendar month. This protocol is typically used in perimenopausal women or those within the first 1 to 2 years of menopause who may still experience withdrawal bleeding. The PEPI trial used 200 mg for 12 days per month and demonstrated effective endometrial protection with an endometrial hyperplasia rate of less than 1% over 3 years, compared with 10% in the unopposed-estrogen group [2].

Continuous dosing prescribes 100 mg nightly without interruption. This approach is preferred for women who are more than 2 years past their final menstrual period, as it avoids cyclic withdrawal bleeding. A study published in Obstetrics & Gynecology (Moyer et al., N=301) found that continuous micronized progesterone at 100 mg daily provided endometrial protection comparable to the cyclic regimen, with amenorrhea rates exceeding 80% at 12 months [5].

The capsules should be taken at bedtime. Oral micronized progesterone produces allopregnanolone, a metabolite that acts on GABA-A receptors and causes drowsiness. Taking the medication at night turns this side effect into a clinical benefit for the roughly 40% to 60% of perimenopausal and postmenopausal women who report sleep disturbances [6]. Patients should take the capsule with food to improve absorption; a pharmacokinetic study showed that fed-state administration increased progesterone AUC by approximately 27% compared with fasting-state dosing [7].

Transferring a Prescription to a Missouri Pharmacy

Patients relocating to Missouri or visiting for an extended period can transfer an existing oral micronized progesterone prescription from another state, as progesterone is not a controlled substance.

Missouri Board of Pharmacy regulations permit prescription transfers for non-controlled medications between licensed pharmacies. The receiving Missouri pharmacy contacts the originating pharmacy directly to transfer the prescription electronically or by phone. No additional prescriber authorization is needed for the transfer itself, though the receiving pharmacist must verify the prescription's validity and remaining refills.

For patients using telehealth platforms based outside Missouri, the prescriber must hold Missouri prescriptive authority or the patient will need to establish care with a Missouri-licensed provider. Most national telehealth platforms that prescribe HRT maintain licenses in all 50 states, so this is rarely an obstacle. The new Missouri provider can access prior medical records and labs to avoid redundant testing, provided the patient authorizes records release.

Patients should plan for a 24- to 48-hour window when transferring prescriptions, as pharmacy-to-pharmacy communication and insurance verification can cause minor delays.

Safety Considerations and Contraindications

Oral micronized progesterone is generally well tolerated, but specific contraindications exist that prescribers in Missouri (and every other state) must screen for before writing the prescription.

Absolute contraindications per the FDA-approved prescribing information include known hypersensitivity to progesterone or any capsule excipient (including peanut oil in Prometrium), undiagnosed abnormal vaginal bleeding, known or suspected breast cancer, active deep vein thrombosis or pulmonary embolism, active arterial thromboembolic disease, and known hepatic impairment or disease [4].

The Women's Health Initiative (WHI) distinguished between synthetic medroxyprogesterone acetate and micronized progesterone regarding breast cancer risk. The E3N French cohort study (N=80,377) followed women for a mean of 8.1 years and found that estrogen combined with micronized progesterone did not significantly increase breast cancer risk (RR 1.00 to 95% CI 0.83 to 1.22), while estrogen plus synthetic progestins carried a relative risk of 1.69 [8]. This data point frequently influences prescriber preference toward micronized progesterone over MPA.

Common side effects include somnolence (reported in approximately 27% of patients in clinical trials), dizziness (24%), and abdominal bloating. These effects are typically mild and improve within the first two to four weeks of use.

Timeline: How Long Until You Receive Progesterone in Missouri

From initial contact to medication in hand, most Missouri patients complete the process within 2 to 7 business days through telehealth, or same-day through an in-person visit if labs are already on file.

A typical telehealth timeline looks like this. Day 1: complete intake and schedule a video visit. Day 2 to 3: lab draw at a local Missouri specimen collection site. Day 3 to 5: lab results return and the prescriber reviews them during a follow-up video call or asynchronous chart review. Day 5 to 7: e-prescription transmitted, pharmacy fills the order, and the patient picks up or receives delivery. In-person visits with an established physician who already has recent labs can result in a same-day prescription and same-day pharmacy pickup at any Missouri retail pharmacy that stocks generic micronized progesterone, which is essentially all of them.

Compounded formulations from 503A pharmacies may take an additional 2 to 5 business days for preparation, since the pharmacy prepares these patient-specific prescriptions on demand rather than stocking pre-made inventory.